论文部分内容阅读
Ｐ＜０．０１，余Ｐ＞０．０５表２医疗体育对老年ＥＨＴ患者血压、ＬＰＯ的影响ｔ检验，同组内与运动前（３年前）比较：＊Ｐ＜０．０５，Ｐ＜０．０１，余Ｐ＞０．０５△．１例死亡。表３医疗体育对老年ＥＨＴ患者血脂的影响ｔ检验。同织内与运动前（３年前）比较，＊Ｐ＜０．０５．余Ｐ＞０．０５△１例死亡。与健康老人相比，老年ＥＨＴ患者血清ＬＰＯ较高（Ｐ＜０．０１），ＨＤＬｃ和ＨＤＬＣ／ＴＣ较低（Ｐ均＜０．０５）。ＥＨＴ患者运动后收缩压和舒张压平均分别降低３．０ｋＰａ和１．３ｋＰａ（Ｐ均＜０．０１）；ＨＤＬｃ平均升高２．１ｍｍｏｌ／Ｌ（Ｐ＜０．０５）；ＬＰＯ显著降低（Ｐ＜０．０５）．３年内非运动组有３例发生脑卒中，４例新发冠心病，１例死亡；而运动组无１例死亡或发生严重心脑血管并发症。讨论近年来研究表明，脂质过氧化反应是许多疾病的发病基础［１］，对动脉粥样硬化的发生起关键作用，与冠心病的发生发展密切相关。本观察发现ＥＬＴ患者血清ＬＰＯ较健康老人明显增高，运动锻炼可使之降至正常水平。可见，ＯＦＲ在ＥＨＴ及其发展中有不可忽视的作用；医疗体育则是降低ＬＰＯ的有效方法之一，对防治ＥＨＴ和抗衰者具有积极作用。推测抗氧化剂的使用对高血压病的?
P <0.01, P> 0.05 Table 2 medical sports on elderly patients with EHT blood pressure, LPO t test, within the same group and before exercise (3 years ago): * P <0.05, P < 0.01, the remaining P> 0.05 △. 1 case died. Table 3 medical sports on elderly patients with EHT lipids t test. Within the same organization and before exercise (3 years ago), * P <0.05. I P> 0.05 △ 1 case of death. Compared with healthy elders, elderly patients with EHT had higher serum LPO (P <0.01) and lower HDLc and HDLC / TC (all P <0.05). The average systolic and diastolic blood pressure of EHT patients decreased by 3.0 kPa and 1.3 kPa (P <0.01), while HDLc increased by 2.1 mmol / L (P <0.05) <0.05). In 3 years non-exercise group had 3 cases of stroke, 4 cases of new-onset coronary heart disease, and 1 case of death. In the exercise group, none of them died or had serious cardiovascular and cerebrovascular complications. Discussion In recent years, studies have shown that lipid peroxidation is the basis of many diseases [1], plays a key role in the occurrence of atherosclerosis, and coronary heart disease is closely related to the occurrence and development. The observation found that serum LPO ELT patients were significantly higher than healthy elderly, exercise can make it to normal levels. It can be seen that OFR plays an important role in EHT and its development. Medical sport is one of the effective ways to reduce LPO, and plays an active role in prevention and treatment of EHT and anti-obesity. Speculated that the use of antioxidants on hypertension?